Skip to content

BridgeBio Pharma

US · BBIO #1254 by market cap Listed 2019
76.03 -2.15 -2.75%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 16 analysts

Buy
Avg price target 110.00 +44.7%
Price target rangecurrent 76.03
Low91.00
Avg110.00
High156.00
Buy 94% Hold 6% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-20 Piper Sandler -- Buy 120.00
2026-11-13 Morgan Stanley -- Buy 91.00
2026-11-02 CCORF -- Buy 108.00
2026-11-02 Barclays -- Buy 156.00
2026-10-30 Wells Fargo -- Buy 102.00
2026-10-30 UBS -- Buy 92.00
2026-10-30 Piper Sandler -- Buy 120.00
2026-10-30 BofA Securities -- Buy --
2026-10-30 Morgan Stanley -- Buy 88.00
2026-10-30 Evercore -- Buy 130.00
2026-10-30 Citi -- Hold 91.00
2026-10-30 RBC Capital -- Buy 100.00
2026-10-29 TD Cowen -- Buy 100.00
2026-10-29 Cantor Fitzgerald -- Buy 110.00
2026-10-29 Wells Fargo -- Buy 102.00
2026-10-25 Cantor Fitzgerald -- Buy 110.00
2026-10-22 Morgan Stanley -- Buy 87.00
2026-10-21 Morgan Stanley -- Buy 87.00
2026-10-20 Citi -- Hold 91.00
2026-10-19 Piper Sandler -- Buy 120.00
2026-10-19 BofA Securities -- Buy 102.00
2026-10-19 Citi -- Hold 91.00
2026-10-16 UBS -- Buy 92.00
2026-10-15 Wells Fargo -- Buy 102.00
2026-10-15 UBS -- Buy 92.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 After close ±10.15% +5.97% (in line)
2026/Q2 2026-08-10 After close ±7.22% -1.15% (in line)
2026/Q1 2026-05-07 After close ±7.23% -0.09% (in line)
2025/Q4 2026-02-24 After close ±11.04% -2.59% (in line)
2025/Q3 2025-10-29 After close ±10.92% -4.88% (in line)
2025/Q2 2025-08-05 After close ±14.51% -8.94% (in line)
2025/Q1 2025-04-29 After close ±12.86% +5.33% (in line)
2024/Q4 2025-02-20 -- ±14.67% +1.42% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:01:24 · For reference only, not investment advice and not tailored to your situation.

BridgeBio Pharma discussion 0 comments

Add a comment